Cannabis and Veganism by Simpa
Our western diet of fast food and our general disregard for our health has meant that our omega ratio is massively unbalanced.
Proapoptotic effect of endocannabinoids in prostate cancer cells
In the early stages, prostate cancer is androgen‑ dependent; therefore, medical castration has shown significant results during the initial stages of this pathology. Despite this early effect, advanced prostate cancer is resilient to such treatment. Recent evidence shows that derivatives of Cannabis sativa and its analogs may exert a protective effect against different types of oncologic pathologies. Based on these results, we suggest that endocannabinoids may be a beneficial option for the treatment of prostate cancer that has become nonresponsive to common therapies.
Adherence to Medical Cannabis Among Licensed Patients in Israel
To evaluate adherence among Israeli patients who are licensed to use medical cannabis and to identify factors associated with adherence to medical cannabis. Our findings show a relatively high adherence rate for medical cannabis, as well as relative safety and high satisfaction among licensed patients. Additionally indicated is the need to develop and implement standardized education about this evolving field-to both patients and physicians.
Best Places in the World to Naturally Grow Cannabis by Paul James
With roots spreading throughout the earth’s soil, with rain to hydrate your plants, and natural sunlight providing all the nutrients your cannabis can possibly need
[A novel analgesics made from Cannabis]
Bayer AG has recently announced that it acquired exclusive rights for the marketing of GW Pharmaceuticals’ new medicine Sativex in Europe and in other regions. Sativex is a sublingual spray on Cannabis extract basis, and is equipped with an electronic tool to facilitate accurate dosing and to prevent misuses. It is standardized for the THC and CBD. The new analgesic is proposed for the treatment of muscle spasticity and pains accompanying multiple sclerosis and as an efficient analgetic for neurogenic pain not responding well to opioids and to other therapies available.
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial
To examine the analgesic efficacy and safety of CT-3 in chronic neuropathic pain in humans. Twenty-one patients (8 women and 13 men) aged 29 to 65 years (mean, 51 years) who had a clinical presentation and examination consistent with chronic neuropathic pain (for at least 6 months) with hyperalgesia (n = 21) and allodynia (n = 7). In this preliminary study, CT-3 was effective in reducing chronic neuropathic pain compared with placebo. No major adverse effects were observed.
A Badgers Journey The Story of his First Public Strain by Subcool
Let’s start from germination: I placed 5 seeds in Riot Rooters in a small dome at 80 degrees.
Cannabinoid-based drugs as anti-inflammatory therapeutics
In the nineteenth century, marijuana was prescribed by physicians for maladies ranging from eating disorders to rabies. However, as newer, more effective drugs were discovered and as the potential for abuse of marijuana was recognized, its use as a therapeutic became restricted, and only recently has its therapeutic potential been re-evaluated.
The Queen of Hash Celebrates in Style by Che Capri
Mila’s regal nickname, The Queen of Hash
Cannabinoids in the treatment of pain and spasticity in multiple sclerosis
There is a large amount of evidence to support the view that the psychoactive ingredient in cannabis, delta9-tetrahydrocannabinol (delta9-THC), and cannabinoids in general, can reduce muscle spasticity and pain under some circumstances. Cannabinoid (CB1) receptors in the CNS appear to mediate both of these effects and endogenous cannabinoids may fulfil these functions to some extent under normal circumstances. H
